Antimicrobial peptides as microbicidal contraceptives: Prophecies for prophylactics - A mini review

European Journal of Contraception and Reproductive Health Care

Volumn 10, Issue 1, 2005, Pages 32-42

  Yedery, R D ^a   Reddy, K V R ^a  

^a NATIONAL INSTITUTE FOR RESEARCH IN REPRODUCTIVE HEALTH   (India)

Author keywords

AMPs; Antimicrobial peptides; Microbicidis

Indexed keywords

ALPHA DEFENSIN; BETA DEFENSIN; CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CECROPIN; CONTRACEPTIVE AGENT; DEFENSIN; MAGAININ A; MAGAININ DERIVATIVE; MELITTIN; NISIN; NISIN A; NISIN Z; NONOXINOL 9; PEPTIDE BMAP 28; PEPTIDE CRAMP; PEPTIDE SMAP 29; PHOSPHOLIPID; POLYPEPTIDE ANTIBIOTIC AGENT; POLYPHEMUSIN; POLYPHEMUSIN II; PROTEGRIN; PROTEGRIN 1; PROTEGRIN 2; PROTEGRIN 3; PROTEGRIN 5; RETROCYCLIN; UNCLASSIFIED DRUG;

ANTIBIOTIC PROPHYLAXIS; ANTIMICROBIAL ACTIVITY; BARRIER CONTRACEPTION; CONDOM; CONTRACEPTION; DRUG EFFICACY; DRUG MECHANISM; GEL; HERPES SIMPLEX VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN STRUCTURE; SEXUAL INTERCOURSE; SEXUAL TRANSMISSION; SEXUALLY TRANSMITTED DISEASE; SHORT SURVEY; SIDE EFFECT; STRUCTURE ANALYSIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADMINISTRATION, TOPICAL; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CONDOMS; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVE AGENTS, MALE; DISEASE TRANSMISSION, HORIZONTAL; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; INTRAUTERINE DEVICES; MALE; PEPTIDES; RISK ASSESSMENT; SEXUALLY TRANSMITTED DISEASES; TREATMENT OUTCOME;

EID: 20344363159     PISSN: 13625187     EISSN: None     Source Type: Journal    
DOI: 10.1080/13625180500035124     Document Type: Short Survey

References (84)

1. Joint United Nations programme on HIV/AIDS. AIDS Epidemic Update: December 1999. Geneva: United Nations, 1999
2. Gerbase AC, Rowley JT, Heymann DHL, Berkley SFB, Piot P. Global prevalence and the incidence estimated of selected curable STDs. Sex Transm Inf 1998;74:12-16
3. Uckun FM, D'Cruz OJ. Prophylactic contraceptives for HIV/AIDS. Hum Reprod update 1999;5:506-14
4. Weber J, Nunn A, Connor O, et al. Chemical condoms for the prevention of HIV infection: evaluation of novel agents against SHIV89.6pd in vitro and in vivo. AIDS 2001;15:1563-8
5. Hill R, Ryan J, Stone A, Fransen L. Vaginal microbicides for the prevention of HIV/AIDS: assessment of the potential market. Int J Pharm Med 2000;14:271-8
6. Rosenberg Z, Van Damme L, Mauck C. Recommendations for the clinical development of topical microbicides: an update. AIDS 2001;15:857-68
7. Greenhead P, Hayes P, Watts P, Laing K, Griffin G, Shattock R. Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides. J Virol 2000;74:5577-86
8. Stone A. Microbicides: The UNAIDS-sponsored trial of nonoxynol-9 gel. IPPF Med Bull 2000;34:3-4
9. Stafford M, Ward H, Flanagan A, et al. Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects. J Acquir Imm Def Syndrome 1998;17:327-31
10. Medzhitov R, Janeway CJ. Advances in immunology: innate immunity. N Engl J Med 2000;343:338-44
11. Lehrer RI, Ganz T. Antimicrobial peptides in mammalian and insect host defense. Curr Opin Immun 1999;11:23-7
12. Colilla FJ, Rocher A, Mendez E. Gamma-purothionins: amino acid sequence of two poly peptides of a new family of thionins from wheat endosperm. FEBS Letters 1990;270:191-4
13. Vizioli J, Salzet M. Antimicrobial peptides: New weapons to control parasitic infections? Trends Parasitol 2002;18:475-6
14. Bulet P, Hetru C, Dimarcq J, Hoffmann D. Antimicrobial peptides from insects: structure and function. Dev Comp Immun 1999;23:329-44
15. Selsted ME, Tang YQ, Morris WL, McGuire PA, Novotney MJ. Purification, primary structures of antimicrobial peptide from bovine neutrophils. J Biol Chem 1993;268:6641-48
16. Schnapp D, Reid CJ, Harris A. Localization and expression of human α-defensin-1 in the pancreas and kidney. J Pathol 1998;186:99-103
17. Barra D, Simmaco M. Amphibian skin: a promising resource for antimicrobial peptides. Trends Biotechnol 1995;13:205-10
18. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2000;415:389-95
19. Hultmark D. Drosophila immunity: paths and patterns. Curr Opin Immunol 2003;15:12-19
20. Nakamura T, Furunaka H, Miyata T, et al. Tachyplesin, a class of antimicrobial peptide from the hemocytes of the horseshoe crab (Tachypleus tridentatus): Isolation and chemical structure. J Biol Chem 1988;263:16709-13
21. Sitaram N, Nagaraj R. Interaction of antimicrobial peptides with biological and model membranes: Structural and charge requirements for activity. Biochim Biophys Acta 1999;1462:29-54
22. Oren Z, Shai Y. Mode of action of linear amphipathic α helical antimicrobial peptides. Biopolymers 1998;47:451-63
23. Cudic M, Otvos L Jr. Intracellular targets of antibacterial peptides, Curr Drug Targets 2002;3:101-6
24. Shai Y. Mechanism of the binding, insertional destabilization of phospholipid bilayer membranes by helical antimicrobial and cell non-selective membrane lytic peptides. Biochim Biophys Acta 1999;1462:55-70
25. White SH, Wimley WC, Selsted ME. Structure, function and membrane integration of defensins. Curr Opin Struct Biol 1995;5:521-7
26. Otvos L Jr. Antibacterial peptides isolated from insects. J Pept Sci 2000;6:497-511
27. Garcia-Olmedo F, Molina A, Alamillo JM, Rodriguez-Palenzuela P. Plant defense peptides. Biopolymers 1998;47:479-91
28. Schroder JM, Harder J. Human β defensin-2. Int J Biochem Cell Biol 1999;31:645-51
29. Lehrer RI, Ganz T. Defensins of vertebrate animals. Curr Opin Immunol 2002;14:96-102
30. Jones DE, Bevins CL. Paneth cells of human small intestine express an antimicrobial peptide gene. J Biol Chem 1992;267:23216-25
31. Schutte BC, Mitros JP, Bartlett JA, et al. Discovery of five conserved β defensin gene clusters using a computational search strategy. Proc Natl Acad Sci USA 2002;99:2129-33
32. Tang YQ, Yuan J, Osapay G, et al. A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated a defensins. Science 1999;286:498-502
33. Daher KA, Selsted ME, Lehrer RI. Direct inactivation of viruses by human granulocyte defensins. J Virol 1986;60:1068-74
34. Lehrer RI, Daher K, Ganz T, Selsted ME. Direct inactivation of viruses by MCP-1 and MCP-2, natural peptide antibiotics from rabbit leukocytes. J Virol 1985;54:467-72
35. Van Strijp JA, Miltenberg LA, Vander Tol ME, Van Kessel KP, Fluit AC, Verhoef J. Degradation of herpes simplex virions by human polymorphonuclear leukocytes and monocytes. J Gen Virol 1990;71:1205-9
36. Sinha S, Cheshenko N, Lehrer RI, Herold BC. NP-1, a rabbit a defensin prevents the entry and intracellular spread of herpes simplex virus type 2. Antimicrob Agents Chemother. 2003;47:494-500
37. Zhang L, Yu Y, He T, et al. Contribution of human α-defensin 1,2 and 3 to the and HIV-1 activity of CD8 antiviral factor. Science 2002;298:995-1000
38. Chang TL, Francois F, Mosoian A, Klotman ME. CAF-mediated human immunodeficiency virus (HIV) type 1 transcriptional inhibition is distinct from α-defensin-1 HIV inhibition. J Biol 2003;77:6777-84
39. Borenstein LA, Ganz T, Sell S, Lehrer RI, Miller JN. Contribution of rabbit leukocyte defensins to the host response in experimental syphilis. Infect Immun 1991;59:1368-77
40. Borenstein LA, Selsted ME, Lehrer RI, Miller JN. Antimicrobial activity of rabbit leukocyte defensins against Treponema pallidum subsp. pallidum. Infect Immun 1991;59:1359-67
41. Yasin B, Harwig SL, Lehrer RI, Wagar EA. Susceptibility of Chlamydia trachomatis to protegrins and defensins. Infect Immun 1996;64:709-13
42. Lehrer RI, Lichtenstein AK, Ganz T. Defensin: antimicrobial and cytotoxic peptides of mammalian cells. Annu Rev Immunol 1993;11:105-28
43. Fahrner RL, Dieckmann T, Harwig SSL, Lehrer RI, Feigon J. Solution structure of protegrin 1, a broad spectrum antimicrobial peptide from porcine leukocytes. Chem Biol 1996;3:543-50
44. Harwig SSL, Swiderek KM, Lee TD, Lehrer RI. Determination of disulfide bridges in PG-2, an antimicrobial peptide from porcine leukocytes. J Peptide Sci 1995;3:207-15
45. Kokryakov VN, Harwig SSL, Panyutich EA, et al. Protegrins, leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins. FEBS Lett 1993;327:231-36
46. Lehrer RI, Panyutich EA, Oren A, et al. Protegrins: mechanisms of bactericidal activity against gram negative bacteria. J Invest Med 1990;43:288-94
47. Qu X, Harwig SL, Oren A, Shafer WM, Lehrer RI. Susceptibilty of Neisseria gonorrhoeae to protegrins. Infect Immun 1996;65:636-9
48. Qu X, Harwig SL, Shafer WM, Lehrer RI. Protegrin structure and activity against Neiserria gonorrhoeae. Infect Immun 1997;65:636-39
49. Tamamura H, Marakami T, Horiuchi S, et al. Synthesis of protegrin-related peptides and their antibacterial and anti-human immunodeficiency virus activity. Chem Pharm Bull 1995;43:853-8
50. Gennaro R, Zanetti M. Structural functions and biological activities of the cathelicidin-derived antimicrobial peptides. Biopolymers 2000;55:31-49
51. Zanetti M, Gennaro R, Romeo D. Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Letters 1995;374:1-5
52. Zanetti M, Litteri L, Gennaro R, Hortsmann H, Romeo D. Bactenecins, defense polypeptides of bovine neutrophils, are generated from precursor molecules stored in the large granules. J Cell Biol 1990;111:1363-71
53. Sorenson OE, Follin P, Johnson AH, et al. Human cathelicidin hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 2001;97:3951-9
54. Travis SM, Anderson NN, Forysth WB, et al. Bactericidal activity of mammalian cathelicidin-derived peptides. Infect Immun 2000;68:2748-55
55. Sambri V, Marangoni A, Giacani L, et al. Comparative in vitro activity of five cathelicidin-derived synthetic peptides against Leptospira, Borrelia and Treponema pallidum. J Antimicrob Chemother 2002;50:895-902
56. Hardy PH Jr, Levin J. Lack of endotoxin in Borrelia hispanica and Treponema pallidum. Proc Soc Expt Biol Med 1983;174:47-52
57. Takayama K, Rothenberg RJ, Barbour AG. Absence of lipopolysaccharide in the Lyme disease spirochete Borrelia burgdorferi. Infect Immun 1987;55:2311-13
58. Zasloff M. Magainins, a class of antimicrobial peptides from xenopus skin. Isolation, characterization of two active forms and partial cDNA sequence of a precursor. Proc Natl Acad Sci USA 1987;84:5449-56
59. Purnasai K, Reddy NP, Babu M. Investigations on wound healing by using amphibian skin. Ind J Exp Biol 1995;33:673-6
60. Zasloff M, Martin B, Chen HC. Antimicrobial activity of synthetic magainin peptides and several analogues. Proc Natl Acad Sci USA 1988;85:910-13
61. Reddy KVR, Shahani SK, Meherji PK. Spermicidal activity of magainins: in vitro and in vivo studies. Contraception 1996;53:205-10
62. Reddy KVR, Majramkar DD. Evaluation of the antifertility effect of magainin-a in rabbits in vitro and in vivo studies. Fertil Steril 2000;73:353-8
63. Reddy KVR, Aranha C. Studies on safety aspects of contraceptive magainin-A in rabbits. Ind J Exp Biol 2000;38:1217-21
64. Aranha C, Majramkar DD, Reddy KVR. Preclinical evaluation of magainin-A as contraceptive antimicrobial agent. Fertil Steril 2004;81:1357-65
65. Hwang PM, Vogel HJ. Structure-function relationships of antimicrobial peptides. Biochem Cell Biol 1998;76:235-46
66. Bechinger B. Structure and functions of channel-forming peptides: magainins, cecropins, melittin and alamethicin. J Membr Biol 1997;156:197-211
67. Moore AJ, Beazley WD, Bibby MC, Devine DA. Antimicrobial activity of cecropins. J Antimicrob Chemother 1996;37:1077-89
68. Ballweber LM, Jaynes JE, Stamm WE, Lampe MF. In vitro microbicidal activitites of cecropin peptides D2A21 and D4E1 and gel formulations containing 0.1% to 2% D2A21 against Chlamydia trachomatis. Antimicrob Agents Chemother 2002;46:34-41
69. Miyata T, Tokunaga F, Yoneya T, et al. Antimicrobial peptides, isolated from horseshoe crab hemocytes, tachyplesin II and polyphemusins I and II. Chemical structures and biological activity. J Biochem 1989;106:663-8
70. Nakashima H, Masuda M, Murakami T, et al. Anti-human immunodeficiency virus activity of a novel synthetic peptide, T22 ([Tyr-5, 12, Lys-7] polyphemusin II): a possible inhibitor of virus-cell fusion. Antimicrob Agents Chemother 1992;36:1249-55
71. Murakami T, Nakajima T, Koyanagi Y, et al. A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection. J Exp Med 1997;186:1389-93
72. Dempsey CE. The actions of melittin on membranes. Biochim Biophys Acta 1990;1031:143-61
73. Wade D, Andreu D, Mitchell SA, et al. Antibacterial peptides designed as analogs or hybrids of cecropins and melittin. Int J Pept Prot Res 1992;40:429-36
74. Esser AF, Bartholomew RM, Jensen FC, Muller-Eberhardt HJ. Disassembly of viral membranes by complement independent channel formation. Proc Natl Acad Sci USA 1979;76:5843-7
75. Wachinger M, Kleinschmidt A, Winder D, et al. Antimicrobial peptides melittin and cecropin inhibit replication of human immunodeficiency virus 1 by suppressing viral gene expression. J Gen Virol, 1998;79:731-40
76. Wachinger M, Saermark T, Erfle V. Influence of amphipathic peptides on the HIV-1 production in persistently infected T-lymphoma cells. FEBS Letters. 1992;309:235-41
77. Breukink E, Kruijff B De. The lantibiotic nisin, a special case or not? Biochim Biophys Acta 1999;1462:223-34
78. Mulders JW, Boerrigter IJ, Rollema HS, Seizen RJ, De Vos W. Identification and characterization of the lantibiotic nisin Z. Eur J Biochem 2001;1991;581-4
79. Delves-Broughton A. Nisin and its uses as a food preservative. Food Technol 1990;44:100-12
80. Clara A, Gupta SM, Reddy KVR. Spermicidal activity of Nisin: in vitro and in vitro studies. Contraception 2004;69:333-42
81. Reddy KVR, Aranha C, Gupta SM, Yedery RD. Evaluation of antimicrobial peptide nisin as a safe vaginal contraceptive agent in rabbits: in vitro and in vivo studies. Reproduction 2004;128:126-37
82. Cole AM, Hong T, Boo LM, et al. Retrocyclin: a primate peptide that protect cells from infection by T- and M-tropic strains of HIV-1. Proc Natl Acad Sci USA, 2002;99:1813-18
83. Wexner SD. Sexually transmitted diseases of the colon, rectum, and anus. The challenge of the nineties. Diseases of the Colon and Rectum 1990;33:1048-62
84. Pye G, Evans DF, Ledingham S, Hardcastle JD. Gastrointestinal intraluminal pH in normal subjects and those with colorectal adenoma or carcinoma. Gut 1990;31:1355-7